Fintech PR

Private Equity Market to Reach $1,098.74 billion, Globally, by 2032 at 9.7% CAGR: Allied Market Research

Published

10 months ago

December 11, 2023

private-equity-market-to-reach-$1,09874-billion,-globally,-by-2032-at-9.7%-cagr:-allied-market-research

One major growth factor for the private equity market is increased interest from institutional investors seeking higher returns in a low-interest-rate environment. Institutions like pension funds and endowments are allocating more capital to private equity due to its potential for superior returns compared to traditional investments like stocks and bonds, driving significant growth in the sector.

WILMINGTON, Del., Dec. 11, 2023 /PRNewswire/ — Allied Market Research published a report, titled, “Private Equity Market by Fund Type (Buyout, Venture Capital, Real Estate, Infrastructure, and Others), and Sector (Technology, Financial Services, Real Estate and Services, Healthcare, Energy and Power, Industrial, and Others): Global Opportunity Analysis and Industry Forecast, 2023–2032″. According to the report, the global private equity market size was valued at $445.4 billion in 2022 and is projected to reach $1,098.74 billion by 2032, growing at a CAGR of 9.7% from 2023 to 2032.

Request Research Report Sample & TOC:
https://www.alliedmarketresearch.com/request-sample/7314

(We are providing report as per your research requirement, including the Latest Industry Insight’s Evolution, Potential and COVID-19 Impact Analysis)

104 – Tables
54 – Charts
351 – Pages

Private equity refers to a form of investment where funds are pooled from various sources, such as institutional investors, high-net-worth individuals, or pension funds, to acquire ownership stakes in private companies. Contrary to publicly traded companies, these investments are not listed on stock exchanges. Private equity firms deploy these funds to purchase a significant portion or the entirety of a company, aiming to enhance its value over time through active management strategies. They work closely with the management of the acquired company, implementing operational improvements, strategic changes, and growth initiatives to maximize its performance and ultimately generate returns for investors. Private equity spans various stages of businesses, from startups to established companies, and often involves restructuring expansion, or turnaround efforts to unlock the full potential of the company before exiting the investment through avenues such as IPOs or sales.

Prime determinants of growth

The private equity market is expected to witness notable growth owing to the potential for higher returns, access to specialized expertise and networks, and flexibility in investment strategies. Moreover, the opportunity for ESG integration is expected to provide a lucrative opportunity for the growth of the market during the forecast period. On the contrary, regulatory and compliance challenges and limited liquidity and exit options limit the growth of the private equity market.

Report Coverage & Details:

Report Coverage	Details
Forecast Period Advertisement	2023–2032
Base Year	2022
Market Size in 2022	$445.4 billion
Market Size in 2032	$1,098.74 billion
CAGR	9.7 %
No. of Pages in Report Advertisement	351
Segments Covered	Fund type, sector, and region.
Drivers	Potential for higher returns Access to specialized expertise and networks Flexibility in investment strategies
Opportunity	Opportunity in ESG integration
Restraints	Regulatory and compliance challenges Advertisement Limited liquidity and exit options

COVID-19 Scenario

COVID-19 had a mixed impact on the private equity market. Initially, there was a downturn as uncertainty and market volatility surged, leading to deal postponements and valuation challenges.
However, as the economy stabilized and rebounded, the market saw increased opportunities for distressed asset acquisitions at attractive valuations. Sectors like technology, healthcare, and e-commerce experienced growth, bolstering the performance of certain private equity portfolios.
Overall, while the pandemic initially posed challenges, it also created avenues for strategic investments and lucrative opportunities, resulting in a mixed impact on the private equity landscape.

Request Customization: https://www.alliedmarketresearch.com/request-for-customization/7314

The buyout segment to maintain its leadership status throughout the forecast period

Based on fund type, the buyout segment held the highest market share in 2022, accounting for nearly one-third of the global private equity market revenue and is estimated to maintain its leadership status throughout the forecast period. This is due to its versatility and applicability across diverse industries. Buyout funds often acquire controlling stakes in established companies, enabling private equity firms to implement strategic changes, drive operational efficiencies, and ultimately generate substantial returns upon exit. However, the infrastructure segment is projected to manifest the highest CAGR of 13.3% from 2023 to 2032. This is due to the global shifts toward sustainable development, increased demand for modern infrastructure, and the focus on renewable energy solutions. Infrastructure investments address critical needs for energy transition, transportation upgrades, and technological advancements, attracting private equity due to long-term revenue potential and the essential nature of these projects.

The technology segment to maintain its leadership status throughout the forecast period

On the basis of sector, the technology segment held the highest market share in 2022, accounting for more than one-fourth of the global private equity market revenue. This is due to its inherent dynamism and potential for disruptive innovation. The attraction of private equity to technology lies in the rapid evolution of the sector, offering opportunities for high-growth investments in areas such as software, AI, and digital platforms. However, the industrial segment is projected to manifest the highest CAGR of 15.1% from 2022 to 2032. This is primarily due to the renewed focus on manufacturing advancements, automation, and Industry 4.0 initiatives. The interest in private equity in the industrial sector has surged due to opportunities to modernize manufacturing processes, embrace technological advancements, and pursue efficiency gains.

North America to maintain its dominance by 2032

On the basis of region, North America held the highest market share for more than one-third of the global private equity market in terms of revenue in 2022. This is due to the fact that the region has a well-established ecosystem for private equity, boasting a mature financial infrastructure, access to a vast pool of capital from institutional investors, and a robust regulatory environment conducive to investment activities. However, Asia-Pacific is expected to witness the fastest CAGR of 12.9% from 2023 to 2032. This is due to the fact that this region boasts rapid economic development, a burgeoning middle class, and an increase in entrepreneurial activity. In addition, there is a growth in openness to private equity investments, favorable demographics, and a rise in number of high-growth potential companies.

Leading Market Players: –

Apollo Global Management, Inc.
Bain Capital, LP.
Blackstone Inc.
EQT AB
HELLMAN & FRIEDMAN LLC
Insight Partners
KOHLBERG KRAVIS ROBERTS & CO. L.P.
Tarrant Capital IP, LLC
The Carlyle Group
Thoma Bravo

The report provides a detailed analysis of these key players in the global private equity market. These players have adopted different strategies such as product launch and agreement to increase their market share and maintain dominant shares in different regions. The report is valuable in highlighting business performance, operating segments, product portfolio, and strategic moves of market players to showcase the competitive scenario.

Key Benefits for Stakeholders

This report provides a quantitative analysis of the private equity market segments, current trends, estimations, and dynamics of the private equity market forecast from 2023 to 2032 to identify the prevailing private equity market opportunity.
Private equity market research is offered along with information related to key drivers, restraints, and opportunities.
Porter’s five forces analysis highlights the potency of buyers and suppliers to enable stakeholders to make profit-oriented business decisions and strengthen their supplier-buyer network.
In-depth analysis of the private equity market segmentation assists to determine the prevailing market opportunities.
Major countries in each region are mapped according to their revenue contribution to the global private equity market.
Private equity market player positioning facilitates benchmarking and provides a clear understanding of the present position of the private equity market players.
The report includes an analysis of the regional as well as global private equity market trends, key players, market segments, application areas, and market growth strategies.

Inquire Before Buying: https://www.alliedmarketresearch.com/purchase-enquiry/7314

Private Equity Market Report Highlights

By Fund Type

Buyout
Venture Capital
Real Estate
Infrastructure
Others

By Sector

Technology
Financial Services
Real Estate and Services
Healthcare
Energy and Power
Industrial
Others

By Region

North America (U.S., Canada)
Europe (UK, Germany, France, Italy, Spain, Rest of Europe)
Asia-Pacific (China, Japan, India, Australia, South Korea, Rest of Asia-Pacific)
LAMEA (Latin America, Middle East, Africa)

Trending Reports in BFSI Industry (Book Now with 10% Discount + COVID-19 Scenario):

Cross-border Payments Market by Channel (Bank Transfer, Money Transfer Operator, Card Payment, Others), by Transaction Type (Business to Business (B2B), Customer to Business (C2B), Business to Customer (B2C), Customer to Customer (C2C)), by Enterprise Size (Large Enterprise Size, Small and Medium-sized Enterprises), by End User (Individuals, Businesses): Global Opportunity Analysis and Industry Forecast, 2023-2032

Autonomous Finance Market by Solution (Asset Management, Auto Payments, Digital Identity Management System, Liquidity Management, Loan Application Processing, Others), by End User (Banks, Financial Institutions, Insurance Companies, Others): Global Opportunity Analysis and Industry Forecast, 2023-2032

Cyber Insurance Market by Coverage (Data Breach, Cyber Liability, First-party Coverage, Third-party Coverage, Others), by Enterprise Size (Large Enterprise, Small and Medium-sized Enterprise), by Industry Vertical (BFSI, IT and Telecommunication, Retail and E-commerce, Healthcare, Manufacturing, Government and Public Sector, Others): Global Opportunity Analysis and Industry Forecast, 2023-2032

Decentralized Finance Market by Component (Blockchain Technology, Decentralized Applications (dApps), Smart Contracts), by Application (Decentralized Exchanges, Compliance and Identity, Marketplaces and Liquidity, Payments, Data and Analytics, Others): Global Opportunity Analysis and Industry Forecast, 2023-2032

E-commerce Market By Model Type (Business-to-consumer (B2C), Business-to-business (B2B)), By Offering (Beauty and Personal Care Products, Consumer Electronics, Fashion and Apparel, Household Products, Others): Global Opportunity Analysis and Industry Forecast, 2023-2032

Exchange Traded Fund Market by Type (Fixed Income/Bonds ETFs, Equity ETFs, Commodity ETFs, Currency ETFs, Specialty ETFs, Others), by Distribution Channel (Retail, Institutional), by Investor Type (Individual Investor, Institutional Investor): Global Opportunity Analysis and Industry Forecast, 2022-2031

About Us:

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Wilmington, Delaware. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports Insights” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Allied Market Research CEO Pawan Kumar is instrumental in inspiring and encouraging everyone associated with the company to maintain high quality of data and help clients in every way possible to achieve success. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

Contact:
David Correa
1209 Orange Street,
Corporation Trust Center,
Wilmington, New Castle,
Delaware 19801 USA.
Int’l: +1-503-894-6022
Toll Free: +1-800-792-5285
UK: +44-845-528-1300
India (Pune): +91-20-66346060
Fax: +1-800-792-5285
[email protected]
Allied Market Research Blog: https://blog.alliedmarketresearch.com
BFSI Blog

Logo: https://mma.prnewswire.com/media/636519/Allied_Market_Research_Logo.jpg

View original content:https://www.prnewswire.co.uk/news-releases/private-equity-market-to-reach-1-098-74-billion-globally-by-2032-at-9-7-cagr-allied-market-research-302011163.html

Fintech PR

Reshaping Finance: Huawei’s Commitment to 4-Zero and Resilient Infrastructure

Published

6 hours ago

October 15, 2024

CISION (PR Newswire)

reshaping-finance:-huawei’s-commitment-to-4-zero-and-resilient-infrastructure

DUBAI, UAE, Oct. 15, 2024 /PRNewswire/ — On the first day of GITEX GLOBAL 2024, the Huawei Finance Forum was held under the theme of Boost Resilience, Reshaping Smarter Finance Together. This forum explored how to build resilient financial infrastructure for the future, as well as digital transformation and ecosystem development to help financial institutions gain a new competitive edge.

Over the past 15 years, China’s finance industry has undergone a significant transformation, largely driven by FinTech giants. As Chinese banks embarked on their digital transformation journey, Huawei developed an FSI solution framework, which focuses on reshaping customers’ resilience, agility, and intelligence.

“The value Huawei brings to our customers is not only in our products and solutions, but also in our unique capabilities, such as best practices worldwide, a global ecosystem, and an extensive digital talent system in China. These capabilities are crucial for customers’ successful transformation.” Shared by Alvin Feng, Director of Global Marketing and Solution Sales, Huawei Digital Finance BU.

Huawei has proposed reshaping resilient financial infrastructure with 4 Zeros: Zero Downtime, Zero Wait, Zero Touch, and Zero Trust. To achieve this, we need to coordinate cloud, network, storage, and computing infrastructure to develop an end-to-end resilient system.

Application modernization is vital for reshaping agility. Huawei has successfully supported many banks in transforming their legacy centralized architecture towards a cloud-native distributed architecture.

In terms of reshaping intelligence. Huawei supports banks in enhancing real-time data operations, a fundamental step for data intelligence. Meanwhile, we actively boost Generative AI adoption in banks through joint innovations in various scenarios.

Dr. Jassim Haji, President of the International Group of Artificial Intelligence, Executive Advisor of HH (His Highness) Nasser Artificial Intelligence Research and Development Center.

“Huawei is pioneering the future of intelligent finance, seamlessly blending AI innovation with enduring infrastructure. Their vision for All Intelligence and commitment to building resilient, secure, and efficient financial ecosystems is transforming the industry, creating smarter, more inclusive services for the AI era.” Said Dr. Jassim Haji, President of the International Group of Artificial Intelligence, Executive Advisor of HH (His Highness) Nasser Artificial Intelligence Research and Development Center.

Roger Wang, Director of Partner Development & Sales, Digital Finance BU, Huawei

“Huawei is continuously collaborating with global and local ecosystem partners to deliver value to customers by developing competitive scenario-based solutions”, stated by Roger Wang, Director of Partner Development & Sales, Digital Finance BU, Huawei. We consistently add value to our customers’ success through our global best practices, business and architecture innovation, and excellent service and support.

For more details, please visit: https://e.huawei.com/en/industries/finance

Photo – https://mma.prnewswire.com/media/2531210/image_986294_58657447.jpg
Photo – https://mma.prnewswire.com/media/2531211/image_986294_58657478.jpg
Photo – https://mma.prnewswire.com/media/2531212/1.jpg

View original content:https://www.prnewswire.co.uk/news-releases/reshaping-finance-huaweis-commitment-to-4-zero-and-resilient-infrastructure-302276872.html

Fintech PR

Qatari Diar Unveils Exclusive Waterfront Townhouses at The Seef Lusail

Published

9 hours ago

October 15, 2024

CISION (PR Newswire)

qatari-diar-unveils-exclusive-waterfront-townhouses-at-the-seef-lusail

Luxury Living Redefined with Attractive Investment Opportunities Starting from QAR 1.7 Million for apartments and QAR 3.4 Million for townhouses in Downtown Lusail

Flexible Payment Plans with 0% Interest and Direct Financing

Freehold Ownership and Residency in Qatar

DOHA, Qatar, Oct. 15, 2024 /PRNewswire/ — Qatari Diar Real Estate Investment Company announced the launch of exclusive upscale waterfront townhouses at The Seef in Downtown Lusail, offering exceptional investment opportunities with 0% interest, direct financing, and flexible payment plans. Lusail represents a bold step forward in sustainable, smart urban living. Known for its state-of-the-art infrastructure and forward-thinking design, Lusail offers a mix of residential, commercial, and entertainment districts just minutes from Qatar’s newest community.

Situated in the heart of Lusail’s waterfront district, The Seef offers a limited collection of luxurious townhouses starting from QAR 3.4 million and apartments starting from QAR 1.7 million. These residences offer immediate occupancy and are designed to provide residents with a blend of modern elegance and comfort. With breathtaking sea views overlooking Qetaifan Islands and Lusail’s iconic skyline, the townhouses redefine modern living.

Lusail’s thriving real estate market presents significant growth potential for investors. The Seef offers freehold ownership, providing residency in Qatar for foreigners. With mortgage financing options from leading local banks, in addition to direct payment plans with 0% interest extending to 6 years for apartments and 4 years for townhouses, owning a luxury residence in The Seef is more accessible than ever. Situated in a location known for attracting substantial foreign investment, The Seef promises robust returns whether for resale or long-term residence.

Eng. Ali Mohamed Al-Ali, CEO of Qatari Diar, said: “The launch of our exclusive waterfront townhouses at The Seef marks a significant milestone in offering unparalleled luxury living in Qatar. Lusail represents more than just a place to live; it’s a lifestyle destination that combines convenience, sophistication and investment potential. With the recent advancements in the Qatari mortgage law, we are thrilled to extend flexible financing options in partnership with several Qatari banks that make owning a piece of this vibrant community achievable for a broader market.”

The Seef’s townhouses are built to meet the diverse needs of residents, from professionals to families. Each townhouse features spacious layouts with high-end finishes, ensuring comfort and luxury at every turn. Residents will enjoy uninterrupted sea views, offering a tranquil escape within the city, and lush green landscapes that create a serene environment for relaxation. The prime location provides proximity to key attractions, including the Meryal Waterpark—the largest in Qatar—Lusail Marina, and Place Vendôme. Located near transit hubs, major highways, shopping centers, healthcare facilities, and educational institutions, The Seef offers residents unparalleled convenience, placing all the vibrant energy of Lusail right at their doorstep.

The Seef reflects Qatari Diar’s commitment to sustainability, with eco-friendly design elements that include energy-efficient infrastructure and green landscaping. The project’s unique architectural innovations, including sky bridge swimming pools and modern areas amenities, such as kids’ playgrounds, squash courts, gym facilities, retail outlets, and serene promenades, sets it apart from typical residential projects, creating a true lifestyle destination.

Prospective buyers and investors are invited to explore The Seef firsthand at the Cityscape Global in Riyadh, Saudi Arabia from 11 – 14 November. Attendees will have the opportunity to learn more about the development, view its luxury offerings, and discover how The Seef can become part of their future in Lusail, Qatar’s city of the future.

For more information, please visit Qatari Diar’s website to explore The Seef and view the full portfolio of investment opportunities.

About Qatari Diar
Qatari Diar Real Estate Company was established in 2005 by the Qatar Investment Authority, the sovereign wealth fund of the State of Qatar. Headquartered northeast of capital, Doha, in the City of Lusail, on the coast of the Arabian Gulf. Qatari Diar was entrusted to support Qatar’s growing economy and to coordinate the country’s real estate development priorities. For more information, visit qataridiar.com.

Logo – https://mma.prnewswire.com/media/2531093/Qatari_Diar_Logo.jpg
Photo – https://mma.prnewswire.com/media/2531089/Qatari_Diar_Seef.jpg
Photo – https://mma.prnewswire.com/media/2531090/Qatari_Diar_Lusail.jpg

View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/qatari-diar-unveils-exclusive-waterfront-townhouses-at-the-seef-lusail-302276626.html

Fintech PR

PharmaMar Announces Positive and Statistically Significant Overall Survival and Progression-Free Survival Results for Zepzelca® (lurbinectedin) and Atezolizumab Combination in First-Line Maintenance Therapy for Extensive-Stage Small Cell Lung Cancer

Published

9 hours ago

October 15, 2024

CISION (PR Newswire)

pharmamar-announces-positive-and-statistically-significant-overall-survival-and-progression-free-survival-results-for-zepzelca-(lurbinectedin)-and-atezolizumab-combination-in-first-line-maintenance-therapy-for-extensive-stage-small-cell-lung-cancer

Jazz plans to submit supplemental New Drug Application (sNDA) to the U.S. Food and Drug Administration (FDA) and PharmaMar will submit Marketing Authorisation Application (MAA) to the European Medicines Agency (EMA) in first half of the year 2025 for this combination therapy as a first-line maintenance treatment for ES-SCLC.

MADRID, Oct. 15, 2024 /PRNewswire/ — PharmaMar (MSE: PHM) and its partner Jazz Pharmaceuticals plc (Nasdaq: JAZZ) have announced today positive top-line results from the Phase 3 clinical trial evaluating Zepzelca^® (lurbinectedin) in combination with the PD-L1 inhibitor atezolizumab (Tecentriq^®) compared to atezolizumab alone when administered as a maintenance treatment for adults with extensive-stage Small Cell Lung Cancer (ES-SCLC) following induction therapy with carboplatin, etoposide and atezolizumab. The combination of lurbinectedin and atezolizumab demonstrated a statistically significant improvement in the primary endpoints of overall survival (OS) and progression-free survival (PFS), as assessed by an independent review facility (IRF), compared to treatment with atezolizumab alone.

“Each year, approximately 63,000 to 72,000 new cases of Small Cell Lung Cancer (SCLC) are reported in Europe. A majority of these patients are diagnosed with extensive stage disease, which is aggressive and often difficult to treat, with poor prognosis,[i]^,[ii]^,[iii]” said Luis Paz-Ares, M.D., Ph.D., head of medical oncology at the Hospital Universitario 12 de Octubre in Madrid, Spain, and IMforte trial principal investigator. “These trial results demonstrate the efficacy of lurbinectedin, in combination with standard-of-care atezolizumab for patients in first-line maintenance treatment, a much-needed advancement for patients with extensive disease.”

“The results of the Phase 3 IMforte trial are highly encouraging and showed a statistically significant benefit for the lurbinectedin and atezolizumab combination for extensive-stage small cell lung cancer patients receiving this treatment in the first-line maintenance setting. These results demonstrate the potential of this regimen to delay disease progression and extend survival for patients with this aggressive disease,” said Rob Iannone, M.D., M.S.C.E., executive vice president, global head of research and development, and chief medical officer of Jazz Pharmaceuticals. “We are pleased with these clinically meaningful results and plan to submit an sNDA in the first half of 2025 to support this combination in the first-line maintenance setting. We thank the investigators and patients who are involved in this trial, along with our partners at Roche.“

“Lurbinectedin monotherapy is currently the standard of care in 2L SCLC. In Europe, it is only approved in Switzerland and early access and compassionate use programs have already allowed some European patients to benefit from lurbinectedin,” said Javier Jiménez, Chief Medical Officer of PharmaMar.

The combination was generally well-tolerated. The preliminary safety data in the ongoing trial is consistent with the known safety profiles of lurbinectedin and atezolizumab with no new safety signals observed in the combination arm.

Jazz and Roche plan to submit these data for presentation at a future medical meeting.

PharmaMar will submit a marketing authorisation application (MAA) to the EMA in the first half of 2025 to request regulatory approval in the European Union (EU). Lurbinectedin is available for use in 16 territories around the world.

Legal warning

This press release does not constitute an offer to sell or the solicitation of an offer to buy securities, and shall not constitute an offer, solicitation or sale in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of that jurisdiction.

About PharmaMar

PharmaMar is a biopharmaceutical company focused on the research and development of new oncology treatments, whose mission is to improve the healthcare outcomes of patients afflicted by serious diseases with our innovative medicines. The Company is inspired by the sea, driven by science, and motivated by patients with serious diseases to improve their lives by delivering novel medicines to them. PharmaMar intends to continue to be the world leader in marine medicinal discovery, development and innovation.

PharmaMar has developed and now commercializes Yondelis® in Europe by itself, as well as Zepzelca® (lurbinectedin), in the US; and Aplidin® (plitidepsin), in Australia, with different partners. In addition, it has a pipeline of drug candidates and a robust R&D oncology program. PharmaMar has other clinical-stage programs under development for several types of solid cancers: lurbinectedin, ecubectedin, PM534 and PM54. Headquartered in Madrid (Spain), PharmaMar has subsidiaries in Germany, France, Italy, Belgium, Austria, Switzerland and The United States. PharmaMar also wholly owns Sylentis, a company dedicated to researching therapeutic applications of gene silencing (RNAi). To learn more about PharmaMar, please visit us at www.pharmamar.com.

About the IMforte Phase 3 Trial

IMforte (NCT05091567) is an ongoing Phase 3, randomized, multicenter maintenance trial evaluating the efficacy, safety and pharmacokinetics of lurbinectedin plus atezolizumab in adults (≥18 years) with ES-SCLC following induction therapy with carboplatin, etoposide and atezolizumab. The primary endpoints for this study are OS and IRF-assessed PFS.

The trial consists of two phases: an induction phase and a maintenance phase. Participants were required to have an ongoing response or stable disease per the Response Evaluation Criteria in Solid Tumors (RECIST) v1.1 after the induction phase of four cycles of carboplatin, etoposide, and atezolizumab to be considered for eligibility screening for the maintenance phase. Eligible participants were randomized in a 1:1 ratio to receive either lurbinectedin plus atezolizumab or atezolizumab in the maintenance phase.

The trial is sponsored by Roche and co-funded by Jazz Pharmaceuticals. Additional information about the trial, including eligibility criteria and a list of clinical trial sites, can be found at: https://clinicaltrials.gov (ClinicalTrials.gov Identifier: NCT05091567).

About Zepzelca^®

Zepzelca^® (lurbinectedin), also known as PM1183, is an analog of the marine compound ET-736 isolated from the sea squirt Ecteinascidia turbinata in which a hydrogen atom has been replaced by a methoxy group. It is a selective inhibitor of the oncogenic transcription programs on which many tumors are particularly dependent. Together with its effect on cancer cells, lurbinectedin inhibits oncogenic transcription in tumor-associated macrophages, downregulating the production of cytokines that are essential for the growth of the tumor. Transcriptional addiction is an acknowledged target in those diseases, many of them lacking other actionable targets.

please visit our website at www.pharmamar.com

[i] Cancer today. (s. f.). https://gco.iarc.who.int/today/en/fact-sheets-populations#regions

[ii] Alvarado-Lunda G, Morales-Espinosa D. Treatment for small cell lung cancer, where are we now? – A review. Transl Lung Cancer Res. 2016;5(1):26-38.

[iii] SEER Explorer Lung and Bronchus Cancer, Recent Trends in SEER Incidence Rates, 2000-2016, by Age, https://seer.cancer.gov/explorer Updated June 27, 2024. Accessed October 10, 2024.

Photo – https://mma.prnewswire.com/media/2530990/PharmaMar.jpg
Logo – https://mma.prnewswire.com/media/2429111/PharmaMar_Logo.jpg